%0 Journal Article
%T HLA class I-restricted MYD88 L265P-derived peptides as specific targets for lymphoma immunotherapy
%A Alexander N. R. Weber
%A Alice F. Muggen
%A Annika Nelde
%A Anton W. Langerak
%A Daniel Johannes Kowalewski
%A Falko Fend
%A Hans-Georg Rammensee
%A Heiko Schuster
%A Helmut Rainer Salih
%A Irina Bonzheim
%A Janet Kerstin Peper
%A Juliane Sarah Walz
%A Lothar Kanz
%A Olaf-Oliver Wolz
%A Rainer Claus
%A Stefan Stevanovi£¿
%A Yamel Cardona Gloria
%J Archive of "Oncoimmunology".
%D 2017
%R 10.1080/2162402X.2016.1219825
%K Cancer vaccine
%K HLA ligandome
%K immunotherapy
%K MyD88 L265P
%K neoantigen
%K non-Hodgkin lymphoma
%K peptide vaccination
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384368/